https://www.selleckchem.com/pr....oducts/direct-red-80
To investigate the optimal treatment pattern in patients with metastatic nasopharyngeal carcinoma (NPC). We assessed 502 consecutive and unselected metastatic NPC patients in Sun Yat-sen University Cancer Center (SYSUCC) from November 2006 to October 2016 in our study. All patients were treated with palliative chemotherapy (PCT) and 308 patients received locoregional radiotherapy (LRRT) subsequently. Our primary study endpoint was overall survival (OS). The patients treated with LRRT were associated with improved survival on univa